Hostname: page-component-6766d58669-kl59c Total loading time: 0 Render date: 2026-05-20T14:44:14.006Z Has data issue: false hasContentIssue false
  • English
  • Français

A Successful Strategy to Decrease Hospital-Onset Clostridium difficile

Published online by Cambridge University Press:  05 January 2018

Lou Ann Bruno-Murtha ,
Rebecca A. Osgood  and
Casey E. Alexandre
Lou Ann Bruno-Murtha*
Affiliation:
Department of Medicine, Cambridge Health Alliance and Harvard Medical School, Cambridge, Massachusetts
Rebecca A. Osgood
Affiliation:
Department of Pathology, Cambridge Health Alliance and Harvard Medical School, Cambridge, Massachusetts
Casey E. Alexandre
Affiliation:
Department of Nursing, Cambridge Health Alliance and Harvard Medical School, Cambridge, Massachusetts
*
Address correspondence to Lou Ann Bruno-Murtha, DO, Department of Medicine, Cambridge Health Alliance and Harvard Medical School, 1493 Cambridge St, Macht 429, Cambridge, MA 02139 (lbruno-murtha@challiance.org).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 2 , February 2018 , pp. 234 - 236
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

PREVIOUS PRESENTATION. Presented as “A successful strategy to reduce hospital-onset Clostridium difficile” (abstract no. 1321) at ID Week 2017 on October 6, 2017, in San Diego, California.

References

REFERENCES

1. Multidrug-resistant organism and Clostridium difficile infection (MDRO/CDI) module. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Published 2017. Accessed October 18, 2017.Google Scholar
2. Dudeck, MA, Weiner, LM, Malpiedi, PJ, Edwards, JR, Peterson, KD, Sievert, DM. Risk adjustment for healthcare facility-onset C. difficile and MRSA bacteremia laboratory-identified event reporting in NHSN. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/mrsa-cdi/riskadjustment-mrsa-cdi.pdf. Published 2013. Accessed October 18, 2017.Google Scholar
3. Gase, KA, Haley, VB, Xiong, K, Van Antwerpen, C, Stricof, RL. Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network’s laboratory-identified event reporting module versus clinical infection surveillance. Infect Control Hosp Epidemiol 2013;34:284–290.Google Scholar
4. Planche, T, Wilcox, MH. Diagnostic pitfalls in Clostridium difficile infection. Infect Dis . Clinics N Amer 2015;29:63–82.Google Scholar
5. C. diff Quik Chek. Alere website. https://www.alere.com/en/home/product-details/c-diff-quik-chek-complete.html. Updated 2017. Accessed December 11, 2017.Google Scholar
6. Surawicz, CM, Brandt, LJ, Binion, DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478–498.CrossRefGoogle ScholarPubMed
7. Tschudin-Sutter, S, Carroll, KC, Tamma, PD, et al. Impact of toxigenic Clostridium difficile colonization on the risk of subsequent C. difficile infection in intensive care unit patients. Infect Control Hosp Epidemiol 2015;36:1324–1329.CrossRefGoogle ScholarPubMed
Supplementary material: File

Bruno-Murtha et al supplementary material

Table S1

Download Bruno-Murtha et al supplementary material(File)
File 12.9 KB